Harnessing the power of cutting-edge AI technologies to streamline the trial design process, improve patient recruitment and ensure that clinical studies are more aligned with real-world data.
Available through EidenAI Suite, Clinical Trials Innovation will be showcased at the Bio-IT World Conference as a “Best of Show Awards” finalist.
Expert.ai, a leading provider of enterprise artificial intelligence solutions for business value creation, today announced the availability of “Clinical Trials Innovation”, an innovative AI-powered solution designed to address some of the most persistent challenges in clinical trials.
Clinical trials are a cornerstone of drug development, but they often face significant hurdles that delay progress and inflate costs. A major challenge is patient recruitment, with 85% of trial sites failing to meet enrollment targets, and nearly 19% of studies failing due to recruitment difficulties*. Furthermore, designing trials that reflect real-world patient populations is complex and resource intensive. Researchers frequently struggle to sift through vast amounts of data to find relevant studies, match eligibility criteria and integrate real-world evidence into their protocols. These inefficiencies often result in costly delays and suboptimal trial designs.
Clinical Trials Innovation addresses these critical challenges by leveraging AI to extract, structure and analyze real-world data, ensuring trial designs are more efficient, data-driven and reflective of actual patient populations. Available through EidenAI Suite – the expert.ai suite of complete, ready-to-use and tailor-made solutions for vertical markets, Clinical Trial Innovations integrates millions of scientific publications, clinical registries and observational studies to provide actionable insights with accuracy and completeness. The heart of Clinical Trials Innovation is its ability to blend different AI methodologies, including neuro-symbolic AI, machine learning, large language models and the groundbreaking addition of agentic AI in 2025, to streamline the trial design process, improve patient recruitment and ensure that clinical studies are more aligned with real-world data.
“With Clinical Trials Innovation, we are proud to bring to the market an innovative AI solution to enable Pharma professionals and Life Sciences researchers to drive clinical trial design by relentlessly learning from real-world evidence,” commented Christophe Aubry, Global Head of Life Sciences & Healthcare, expert.ai. “The capability of integrating structured and unstructured data sources to make more informed decisions when automating trial design processes represents a paradigm shift in the future of drug development. The result is a faster, more efficient and more successful process that can help bring life-saving therapies to market faster.”
Clinical Trials Innovation Shortlisted for Bio-IT “Best of Show Awards” 2025
Clinical Trials Innovation has already made waves in the industry, being shortlisted for the prestigious Best of Show Awards – Bio-IT World Conference & Expo 2025. This recognition highlights the groundbreaking approach and exceptional innovation in technologies used by Pharma and Life Sciences professionals.
*https://www.scirp.org/journal/paperinformation?paperid=128354
